SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as shares face intense pressure from an ongoing antitrust legal battle with a coalition of state attorneys general, leading investors to closely watch for a potential out-of-court settlement before rising financial penalties accrue. While some in the community advocate for a strategic pivot like divesting CNN to break the regulatory deadlock, others remain bullish on the long-term potential of the Warner Bros. Discovery merger and are actively accumulating shares at these multi-year lows.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing significant volatility and aggressive debate as investors react to the accelerated lockup expiration and its impact on the fund's heavy exposure to private AI and space leaders like Anthropic and SpaceX. While some community members view the current price as a potential dip-buying opportunity ahead of future IPOs, others are sounding alarms over the fund's premium to its net asset value and the looming selling pressure from retail holders.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors respond to a series of positive clinical trial updates and active preparation for a Biologics License Application (BLA) submission for its lead prostate cancer asset expected in the final quarter of the year. Community members are actively debating the company's manufacturing progress, potential for a future acquisition by a major pharmaceutical player, and the long-term market opportunity for its immunotherapy platform.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently trending as investors weigh strong earnings and an improved outlook against ongoing volatility and sector-wide weakness. The community is actively debating whether the recent share price decline represents a buying opportunity in a fundamental AI growth story or if broader macro concerns and cyclical rotation will continue to pressure the stock.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is rallying on strong commercial momentum, highlighted by record-breaking quarterly revenue and significant margin expansion, which has spurred optimism regarding its pipeline of next-generation TIL therapies. The community is actively discussing the stock's potential as a takeover target or a platform leader, particularly as they await pivotal upcoming data in lung cancer, which is widely viewed as a massive addressable market.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with knife is generating significant momentum as the community rallies around its multichain expansion and active development. Investors are highlighting the project's viral meme culture and decentralized, community-led structure as key drivers for their long-term conviction.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is rallying as investors sentiment shifts due to strengthening software sector fundamentals, persistent institutional buying, and speculation surrounding a potential short squeeze given the stock's elevated short interest. Community discussions are centered on the company's strategic pivot toward agentic AI orchestration and the anticipation of its upcoming earnings report as a critical catalyst for further upside.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as institutional ownership rises to approximately 90%, fueling community speculation that major pharmaceutical players are accumulating shares for a potential acquisition or strategic buyout. Investors are actively discussing the company's pivot to a licensing-heavy model and anticipating further updates on Matrix-M partnerships and the progress of the Sanofi COVID-influenza combination vaccine following recent earnings.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened market attention following a record quarter of revenue growth, with the company raising its full-year guidance and highlighting a robust cash position as it accelerates its quantum commercialization. While some investors are concerned by wider operating losses, the community is largely focused on the potential for upcoming government contracts and technical milestones to catalyze future growth.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is currently facing significant selling pressure amid broader market uncertainty surrounding Chinese regulatory scrutiny and e-commerce price war concerns. While some in the community see the current valuation as an attractive entry point given the company's strong cash position and ongoing share buybacks, others are frustrated by the stock's lack of momentum and recent downward price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


BadatStocks2023

BadatStocks2023